UTHR.NASDAQUnited Therapeutics CORP
Form 4: UNITED THERAPEUTICS CEO Sells Shares
Sentiment:
Insider Transaction (Form 4)
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on October 6, 2026.
Summary
- Option exercise/conversion: acquired 9,500 Common Stock at $117.76 ($1,118,720) on October 6, 2026; holds 333,943 after (Indirect).
- Open-market sale: disposed of 280 Common Stock at $527.90 ($147,813) on October 6, 2026; holds 333,663 after (Indirect).
- Open-market sale: disposed of 360 Common Stock at $528.72 ($190,339) on October 6, 2026; holds 333,303 after (Indirect).
- Open-market sale: disposed of 240 Common Stock at $530.13 ($127,232) on October 6, 2026; holds 333,063 after (Indirect).
- Open-market sale: disposed of 320 Common Stock at $531.94 ($170,220) on October 6, 2026; holds 332,743 after (Indirect).
- Open-market sale: disposed of 215 Common Stock at $533.14 ($114,626) on October 6, 2026; holds 332,528 after (Indirect).
- Open-market sale: disposed of 167 Common Stock at $534.30 ($89,228) on October 6, 2026; holds 332,361 after (Indirect).
- Open-market sale: disposed of 734 Common Stock at $535.71 ($393,210) on October 6, 2026; holds 331,627 after (Indirect).
- Open-market sale: disposed of 323 Common Stock at $536.25 ($173,209) on October 6, 2026; holds 331,304 after (Indirect).
- Open-market sale: disposed of 133 Common Stock at $537.58 ($71,498) on October 6, 2026; holds 331,171 after (Indirect).
- Open-market sale: disposed of 1,088 Common Stock at $538.61 ($586,006) on October 6, 2026; holds 330,083 after (Indirect).
- Open-market sale: disposed of 1,606 Common Stock at $539.68 ($866,718) on October 6, 2026; holds 328,477 after (Indirect).
- Open-market sale: disposed of 2,054 Common Stock at $540.68 ($1,110,553) on October 6, 2026; holds 326,423 after (Indirect).
- Open-market sale: disposed of 380 Common Stock at $541.55 ($205,791) on October 6, 2026; holds 326,043 after (Indirect).
- Open-market sale: disposed of 120 Common Stock at $542.49 ($65,099) on October 6, 2026; holds 325,923 after (Indirect).
- Open-market sale: disposed of 558 Common Stock at $543.99 ($303,548) on October 6, 2026; holds 325,365 after (Indirect).
- Open-market sale: disposed of 842 Common Stock at $544.75 ($458,681) on October 6, 2026; holds 324,523 after (Indirect).
- Open-market sale: disposed of 80 Common Stock at $545.50 ($43,640) on October 6, 2026; holds 324,443 after (Indirect).
- Option exercise/conversion: disposed of 9,500 Stock Option on October 6, 2026; holds 290,410 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $5,117,412 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Martine A Rothblatt — Director, Officer (Chairperson & CEO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-06 | Option exercise/conversion | Common Stock | 9,500 | $118 | $1.1M | 333,943 |
| 2026-10-06 | Open-market sale | Common Stock | 280 | $528 | $147.8K | 333,663 |
| 2026-10-06 | Open-market sale | Common Stock | 360 | $529 | $190.3K | 333,303 |
| 2026-10-06 | Open-market sale | Common Stock | 240 | $530 | $127.2K | 333,063 |
| 2026-10-06 | Open-market sale | Common Stock | 320 | $532 | $170.2K | 332,743 |
| 2026-10-06 | Open-market sale | Common Stock | 215 | $533 | $114.6K | 332,528 |
| 2026-10-06 | Open-market sale | Common Stock | 167 | $534 | $89.2K | 332,361 |
| 2026-10-06 | Open-market sale | Common Stock | 734 | $536 | $393.2K | 331,627 |
| 2026-10-06 | Open-market sale | Common Stock | 323 | $536 | $173.2K | 331,304 |
| 2026-10-06 | Open-market sale | Common Stock | 133 | $538 | $71.5K | 331,171 |
| 2026-10-06 | Open-market sale | Common Stock | 1,088 | $539 | $586.0K | 330,083 |
| 2026-10-06 | Open-market sale | Common Stock | 1,606 | $540 | $866.7K | 328,477 |
| 2026-10-06 | Open-market sale | Common Stock | 2,054 | $541 | $1.1M | 326,423 |
| 2026-10-06 | Open-market sale | Common Stock | 380 | $542 | $205.8K | 326,043 |
| 2026-10-06 | Open-market sale | Common Stock | 120 | $542 | $65.1K | 325,923 |
| 2026-10-06 | Open-market sale | Common Stock | 558 | $544 | $303.5K | 325,365 |
| 2026-10-06 | Open-market sale | Common Stock | 842 | $545 | $458.7K | 324,523 |
| 2026-10-06 | Open-market sale | Common Stock | 80 | $545 | $43.6K | 324,443 |
| 2026-10-06 | Option exercise/conversion | Stock Option | 9,500 | — | — | 290,410 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-06 | Option exercise/conversion (9,500 shares) |
| 2026-10-06 | Open-market sale (280 shares) |
| 2026-10-06 | Open-market sale (360 shares) |
| 2026-10-06 | Open-market sale (240 shares) |
| 2026-10-06 | Open-market sale (320 shares) |
| 2026-10-06 | Open-market sale (215 shares) |
| 2026-10-06 | Open-market sale (167 shares) |
| 2026-10-06 | Open-market sale (734 shares) |
| 2026-10-06 | Open-market sale (323 shares) |
| 2026-10-06 | Open-market sale (133 shares) |
| 2026-10-06 | Open-market sale (1,088 shares) |
| 2026-10-06 | Open-market sale (1,606 shares) |
| 2026-10-06 | Open-market sale (2,054 shares) |
| 2026-10-06 | Open-market sale (380 shares) |
| 2026-10-06 | Open-market sale (120 shares) |
| 2026-10-06 | Open-market sale (558 shares) |
| 2026-10-06 | Open-market sale (842 shares) |
| 2026-10-06 | Open-market sale (80 shares) |
| 2026-10-06 | Option exercise/conversion (9,500 shares) |
Keywords
insider transaction, Form 4, UTHR, UNITED THERAPEUTICS Corp, bearish, Martine A Rothblatt
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.